CJ
Congress trade
Rep. Christopher Jacobs (R-NY) sold $1K-$15K of Reata Pharmaceuticals, Inc. (RETA) stock
Christopher Jacobs, U.S. Representative (R-NY), disclosed a sale of Reata Pharmaceuticals, Inc. (RETA) stock worth $1K-$15K in a STOCK Act filing on Feb 17, 2021.
The trade happened on Jan 4, 2021, 44 days before it was made public.
- Traded
- Jan 4, 2021
- Disclosed
- Feb 17, 2021
- Filing delay
- 44 days
- Source
- STOCK Act disclosure
Other trades in this disclosure (31)
- SellBRK.B$50K-$100KFeb 17, 2021
- SellUNH$15K-$50KFeb 17, 2021
- SellWMT$15K-$50KFeb 17, 2021
- SellAAPL$1K-$15KFeb 17, 2021
- SellARW$1K-$15KFeb 17, 2021
- SellASMB$1K-$15KFeb 17, 2021
- SellBAC$1K-$15KFeb 17, 2021
- SellBIIB$1K-$15KFeb 17, 2021
- SellCCEP$1K-$15KFeb 17, 2021
- SellCMP$1K-$15KFeb 17, 2021
- SellCOP$1K-$15KFeb 17, 2021
- SellECL$1K-$15KFeb 17, 2021
- SellF$1K-$15KFeb 17, 2021
- SellGOOG$1K-$15KFeb 17, 2021
- SellHD$1K-$15KFeb 17, 2021
- SellHRL$1K-$15KFeb 17, 2021
- SellIBM$1K-$15KFeb 17, 2021
- SellJNJ$1K-$15KFeb 17, 2021
- SellLB$1K-$15KFeb 17, 2021
- SellMCD$1K-$15KFeb 17, 2021
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.